JP Morgan Private Wealth Advisors’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio TBRA Stock Details TBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-25,000	Closed	-$994K	–	1337
2016 Q3	$994K	Buy	+25,000	New	+$279K	0.01%	595

JP Morgan Private Wealth Advisors's TBRA Position: Q4 2016 in Review

JP Morgan Private Wealth Advisors sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 25,000 shares — an estimated $994K sold.

JP Morgan Private Wealth Advisors first reported a position in TBRA in Q3 2016 and held it in 1 quarter. The position peaked at $994K in Q3 2016. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.

JP Morgan Private Wealth Advisors reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
JP Morgan Private Wealth Advisors sold 25,000 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $994K.
JP Morgan Private Wealth Advisors first reported a position in Tobira Therapeutics, Inc. Common Stock in Q3 2016 and held it in 1 quarter.
JP Morgan Private Wealth Advisors's Tobira Therapeutics, Inc. Common Stock position peaked at $994K in Q3 2016.
0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.